At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 81 enrolled
Drug / intervention
clobetasol propionate spray 0.05% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Clobetasol Propionate Spray Versus Vehicle for the Management of Moderate to Severe Plaque Psoriasis of the Scalp
In Brief
A Phase 4 clinical trial evaluating clobetasol propionate spray 0.05% and Vehicle spray for Scalp Psoriasis. Completed, enrolled 81 participants across 4 sites.
Detailed Summary
The primary objective of this study is to evaluate the safety and efficacy of clobetasol propionate spray versus vehicle spray for the management of moderate to severe plaque psoriasis of the scalp.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScalp Psoriasis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
First PostedApr 2009
Primary CompletionDec 2009
TodayJul 2026
First PostedApr 15, 2009
Enrollment StartApr 1, 2009
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 17.2 years ago
Interventions
clobetasol propionate spray 0.05%drug
Apply enough product to cover affected areas topically twice daily at least 8 hours apart
Vehicle spraydrug
Apply enough product to cover affected areas topically twice daily at least 8 hours apart